Sylvia Bartel

1.0k total citations
20 papers, 767 citations indexed

About

Sylvia Bartel is a scholar working on Emergency Medical Services, Geriatrics and Gerontology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Sylvia Bartel has authored 20 papers receiving a total of 767 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Emergency Medical Services, 7 papers in Geriatrics and Gerontology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Sylvia Bartel's work include Patient Safety and Medication Errors (7 papers), Pharmaceutical Practices and Patient Outcomes (7 papers) and Pharmaceutical studies and practices (5 papers). Sylvia Bartel is often cited by papers focused on Patient Safety and Medication Errors (7 papers), Pharmaceutical Practices and Patient Outcomes (7 papers) and Pharmaceutical studies and practices (5 papers). Sylvia Bartel collaborates with scholars based in United States and India. Sylvia Bartel's co-authors include Lawrence N. Shulman, Maureen Connor, Saul N. Weingart, Lucian L. Leape, Ann H. Partridge, David W. Bates, Jeffrey M. Rothschild, Tejal K. Gandhi, Elisabeth Burdick and Jonathan A. Flug and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Sylvia Bartel

18 papers receiving 729 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sylvia Bartel United States 13 251 208 205 180 130 20 767
Vérane Schwiertz France 14 170 0.7× 151 0.7× 103 0.5× 129 0.7× 52 0.4× 31 607
Raymond J. Muller United States 10 231 0.9× 163 0.8× 233 1.1× 104 0.6× 203 1.6× 20 822
Kristine B. LeFebvre United States 12 178 0.7× 148 0.7× 200 1.0× 109 0.6× 126 1.0× 21 650
John Valgus United States 14 252 1.0× 88 0.4× 174 0.8× 52 0.3× 141 1.1× 36 643
Martha Polovich United States 16 206 0.8× 196 0.9× 373 1.8× 281 1.6× 123 0.9× 30 1.2k
Loris Zanier Italy 16 33 0.1× 80 0.4× 46 0.2× 37 0.2× 12 0.1× 43 671
Eli J. Korner United States 11 155 0.6× 102 0.5× 44 0.2× 51 0.3× 90 0.7× 20 651
M.‐C. Woronoff‐Lemsi France 8 47 0.2× 69 0.3× 35 0.2× 35 0.2× 4 0.0× 26 335
Eric M. Tichy United States 14 87 0.3× 50 0.2× 175 0.9× 11 0.1× 49 0.4× 40 615
Anna Bergkvist Sweden 8 266 1.1× 59 0.3× 59 0.3× 125 0.7× 96 0.7× 11 627

Countries citing papers authored by Sylvia Bartel

Since Specialization
Citations

This map shows the geographic impact of Sylvia Bartel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvia Bartel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvia Bartel more than expected).

Fields of papers citing papers by Sylvia Bartel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvia Bartel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvia Bartel. The network helps show where Sylvia Bartel may publish in the future.

Co-authorship network of co-authors of Sylvia Bartel

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvia Bartel. A scholar is included among the top collaborators of Sylvia Bartel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvia Bartel. Sylvia Bartel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leblebjian, Houry, Brett Glotzbecker, Mark M. Awad, et al.. (2019). Outcomes of immunotherapy administration for hospitalized cancer patients.. Journal of Clinical Oncology. 37(15_suppl). e18225–e18225. 1 indexed citations
2.
Burt, Bryan M., William G. Richards, Hyun‐Sung Lee, et al.. (2018). A Phase I Trial of Surgical Resection and Intraoperative Hyperthermic Cisplatin and Gemcitabine for Pleural Mesothelioma. Journal of Thoracic Oncology. 13(9). 1400–1409. 35 indexed citations
3.
Rabin, Michael S., et al.. (2018). Reducing infusion wait time: An initiative to increase early signing of medication orders by providers at a comprehensive cancer center.. Journal of Clinical Oncology. 36(30_suppl). 123–123.
4.
Bartel, Sylvia, et al.. (2018). Multicenter evaluation of a new closed system drug-transfer device in reducing surface contamination by antineoplastic hazardous drugs. American Journal of Health-System Pharmacy. 75(4). 199–211. 21 indexed citations
5.
Rabin, Michael S., et al.. (2018). Reducing infusion wait time: Redesigning medication order verification workflow at a comprehensive cancer center.. Journal of Clinical Oncology. 36(30_suppl). 129–129.
6.
Goldspiel, Barry R., James M. Hoffman, Niesha Griffith, et al.. (2015). ASHP Guidelines on Preventing Medication Errors with Chemotherapy and Biotherapy. American Journal of Health-System Pharmacy. 72(8). e6–e35. 63 indexed citations
7.
Cotugno, Michael, et al.. (2014). Denosumab in hypercalcemia of malignancy: A case series. Journal of Oncology Pharmacy Practice. 21(2). 143–147. 27 indexed citations
8.
Leblebjian, Houry, Daniel J. DeAngelo, Richard M. Stone, et al.. (2013). Predictive factors for all-trans retinoic acid-related differentiation syndrome in patients with acute promyelocytic leukemia. Leukemia Research. 37(7). 747–751. 15 indexed citations
9.
Weingart, Saul N., Anne Gross, Sylvia Bartel, et al.. (2010). Medication errors involving oral chemotherapy. Cancer. 116(10). 2455–2464. 67 indexed citations
10.
Leblebjian, Houry, Anne McDonnell, Martha Wadleigh, et al.. (2010). Predictive Factors for All-Trans Retinoic Acid Related Differentiation Syndrome In Acute Promyelocytic Leukemia.. Blood. 116(21). 1052–1052. 2 indexed citations
11.
Weingart, Saul N., Jonathan A. Flug, Ann H. Partridge, et al.. (2007). Oral chemotherapy safety practices at US cancer centres: questionnaire survey. BMJ. 334(7590). 407–407. 93 indexed citations
12.
Connor, Maureen, et al.. (2007). Creating a Fair and Just Culture: One Institution’s Path Toward Organizational Change. The Joint Commission Journal on Quality and Patient Safety. 33(10). 617–624. 28 indexed citations
13.
Bartel, Sylvia. (2007). Safe practices and financial considerations in using oral chemotherapeutic agents. American Journal of Health-System Pharmacy. 64(9_Supplement_5). S8–S14. 53 indexed citations
14.
Goodin, Susan, Joseph Aisner, Sylvia Bartel, & Carol Viele. (2007). Current issues associated with oral chemotherapy: A roundtable discussion. American Journal of Health-System Pharmacy. 64(9_Supplement_5). S33–S35. 3 indexed citations
15.
Nathan, David G., Edward J. Benz, Lawrence N. Shulman, et al.. (2006). Key Learning from the Dana-Farber Cancer Institute's 10-Year Patient Safety Journey. 10 indexed citations
16.
Gandhi, Tejal K., Sylvia Bartel, Lawrence N. Shulman, et al.. (2005). Medication safety in the ambulatory chemotherapy setting. Cancer. 104(11). 2477–2483. 165 indexed citations
17.
McCollum, Andrea M., Matthew H. Kulke, David P. Ryan, et al.. (2004). Lack of Efficacy of Streptozocin and Doxorubicin in Patients With Advanced Pancreatic Endocrine Tumors. American Journal of Clinical Oncology. 27(5). 485–488. 83 indexed citations
18.
Bartel, Sylvia, et al.. (2001). Variation in Administration of Cyclophosphamide and Mesna in the Treatment of Childhood Malignancies. Journal of Pediatric Oncology Nursing. 18(1). 37–45. 12 indexed citations
19.
Holdsworth, Mark T., et al.. (2000). Stratified Administration of Serotonin 5-HT3 Receptor Antagonists (Setrons) for Chemotherapy-Induced Emesis. PharmacoEconomics. 18(6). 533–556. 17 indexed citations
20.
Rubin, Eric H., Ajit Bharti, Dorothy H. Trites, et al.. (1995). A phase I and pharmacokinetic study of a new camptothecin derivative, 9-aminocamptothecin.. PubMed. 1(3). 269–76. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vérane Schwiertz Breakdown of academic impact, for papers by Raymond J. Muller Breakdown of academic impact, for papers by Kristine B. LeFebvre Breakdown of academic impact, for papers by John Valgus Breakdown of academic impact, for papers by Martha Polovich Breakdown of academic impact, for papers by Loris Zanier Breakdown of academic impact, for papers by Eli J. Korner Breakdown of academic impact, for papers by M.‐C. Woronoff‐Lemsi Breakdown of academic impact, for papers by Eric M. Tichy Breakdown of academic impact, for papers by Anna Bergkvist
Rankless by CCL
2026